Ratings by Rodman & Renshaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/21/2026 | Seema Sheoran | Eledon Pharamceuticals | ELDN | New Coverage | Buy (N/A) |
12.00 (N/A) |
3.86 (3.95) |
2.33% | Details |
| 7/7/2026 | Michael King Jr. | Atossa Genetics | ATOS | New Coverage | Buy (N/A) |
12.00 (N/A) |
2.28 (2.40) |
5.26% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 80 more... | |||||||||
